Related Experiment Videos
Affinity purification and characterization of recombinant human galectin-1
M Fouillit1, M Lévi-Strauss, V Giudicelli
1Biochimie Cellulaire des Hémopathies Lymphoïdes, UFR SMBH-Léonard de Vinci, Université Paris Nord, Bobigny, France.
Summary
Recombinant galectin-1 (rGAL1), produced in E. coli, was purified and characterized. This rGAL1 induced concentration-dependent cell death in Jurkat T-lymphoblastoid cells, highlighting its biological activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Galectin-1 is a protein involved in cell growth and apoptosis.
- Understanding recombinant galectin-1 (rGAL1) function is crucial for its therapeutic potential.
Purpose of the Study:
- To overexpress and purify galectin-1 in E. coli.
- To characterize the biophysical properties of rGAL1.
- To investigate the biological activity of rGAL1 on Jurkat T-lymphoblastoid cells.
Main Methods:
- Bacterial overexpression of galectin-1.
- Affinity chromatography using lactose-coupled agarose for purification.
- Two-dimensional electrophoresis (IPG-DALT) for protein characterization.
- Cell-based assays to assess cytotoxicity.
Main Results:
- Successfully purified homogeneous recombinant galectin-1 (rGAL1).
- rGAL1 exhibited a distinct isoelectric point (pI 5.4) compared to human tissue galectin-1 (pI 5.1).
- rGAL1 demonstrated concentration-dependent induction of cell death in Jurkat T-lymphoblastoid cells.
Conclusions:
- Recombinant galectin-1 can be effectively produced and purified using E. coli expression systems.
- The characterized rGAL1 retains biological activity, inducing apoptosis in T-lymphoblastoid cells.
- This study provides a foundation for further investigation into galectin-1's role in cellular processes and potential therapeutic applications.